Ayfer Gözü Pirinççioğlu*, Deniz Gökalp and Murat Söker
Background: Hypoparathyroidism is well known to occur in thalassemia major patients, but it is thought to be uncommon and its incidence is considered to be decreasing with improvements in chelation therapy. The
objective of this study was to assess the prevalence of parathyroid dysfunction in the fi rst decade of life of the patients with thalassemia major.
Sathit Niramitmahapanya*, Surasak Kaoiean, Varaporn Sangtawesin, Anusorn Patpanaprapan, Narisa K Bordeerat and Chaicharn Deerochanawong
Background: Vitamin D defi ciency in pregnancy increases several risks of breastfed mothers. To prevent these adverse events, vitamin D supplementation during pregnancy and lactation is recommended, but suggested dose ranges vary.
Objective: To determine whether vitamin D3 1,800 IU/d supplementation in lactating mothers improves the vitamin D status of their breastfed infants.
Gabriele Cioni*, Rossella Marcucci, Rosanna Abbate and Giovanna D’Alessandri
Introduction: Lipoprotein (a) [Lp(a)] is a marker for cardiovascular disease, involved in pathogenesis and progression of atherosclerosis. In selected high-risk patients, lipoprotein-apheresis could optimize secondary prevention and improve prognosis.
Aim: We presented the case of a 49-year-old man with high lipoprotein (a) levels and recurrent cardiac adverse events, despite maximal pharmacological therapy.Introduction: Lipoprotein (a) [Lp(a)] is a marker for cardiovascular disease, involved in pathogenesis and